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ABSTRACT: Multimodal chemical imaging using matrix-
assisted laser desorption/ionization mass spectrometry
(MALDI-MS) can provide comprehensive molecular informa-
tion in situ within the same tissue sections. This is of relevance
for studying different brain pathologies such as Alzheimer’s
disease (AD), where recent data suggest a critical relevance of
colocalizing Aβ peptides and neuronal lipids. We here
developed a novel trimodal, high-resolution (10 μm)
MALDI imaging MS (IMS) paradigm for negative and positive
ion mode lipid analysis and subsequent protein ion imaging on
the same tissue section. Matrix sublimation of 1,5-diamino-
naphthalene (1,5-DAN) enabled dual polarity lipid MALDI
IMS on the same pixel points at high spatial resolutions (10
μm) and with high spectral quality. This was followed by 10 μm resolution protein imaging on the same measurement area,
which allowed correlation of lipid signals with protein distribution patterns within distinct cerebellar regions in mouse brain. The
demonstrated trimodal imaging strategy (IMS3) was further shown to be an efficient approach for simultaneously probing Aβ
plaque-associated lipids and Aβ peptides within the hippocampus of 18 month-old transgenic AD mice (tgArcSwe). Here, IMS3
revealed a strong colocalization of distinct lipid species including ceramides, phosphatidylinositols, sulfatides (Cer 18:0, PI 38:4,
ST 24:0) and lysophosphatidylcholines (LPC 16:0, LPC 18:0) with plaque-associated Aβ isoforms (Aβ 1−37, Aβ 1−38, Aβ 1−
40). This highlights the potential of IMS3 as an alternative, superior approach to consecutively performed immuno-based Aβ
staining strategies. Furthermore, the IMS3 workflow allowed for multimodal in situ MS/MS analysis of both lipids and Aβ
peptides. Altogether, the here presented IMS3 approach shows great potential for comprehensive, high-resolution molecular
analysis of histological features at cellular length scales with high chemical specificity. It therefore represents a powerful approach
for probing the complex molecular pathology of, e.g., neurodegenerative diseases that are characterized by neurotoxic protein
aggregation.
KEYWORDS: MALDI imaging mass spectrometry, trimodal MALDI imaging MS, Alzheimer’s disease, plaque pathology,
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■ INTRODUCTION
Matrix-assisted laser desorption/ionization based imaging mass
spectrometry (MALDI-IMS) is a rapidly developing technique
for spatial profiling of endogenous biochemical species in situ
including metabolites,1 peptides,2 proteins,2,3 and lipids.4,5 The
suitability of MALDI-IMS for comprehensive, unlabeled, spatial
analysis for a wide range of chemical species in situ makes it a
powerful technique to probe the molecular histopathology in
complex biological tissues, such as brain tissue.6 Although
MALDI-IMS has been successfully applied for a variety of
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biomedical analysis,7−9 the fundamental factors affecting
selectivity, ionization efficiency, sensitivity, mass resolution,
and reproducibility are still not fully understood.10−12 This is
due to the complexity of the ionization process and the
interaction of the laser with the matrix compound, competing
charge generation and transfer processes in laser desorption
plumes, as well as different physicochemical properties of the
matrix and analyte molecules.9−11,13−15 Therefore, the choice of
the matrix compound and matrix application strategy are
important factors as all matrix compounds have varying
restrictions with respect to analyte selectivity (e.g., lipids,
proteins), analyte polarity, crystal size, and optimal matrix
application conditions.6 In order to perform comprehensive
imaging of lipids, peptides, and proteins, typically multiple
analyses on consecutive tissue sections are required per
biological sample using different matrix preparation approaches.
However, in these cases, the correlation of molecular
histopathology is challenging, as anatomical features can vary
from one tissue section to another, if their size is not exceeding
the thickness of the tissue section. With respect to the diversity
in biomolecular histopathology associated with different
diseases, it is therefore desired to correlate molecular
information with histological features on the same tissue
section.
So far, only few studies have demonstrated subsequent
MALDI-IMS analysis on a single tissue section.5,6,16−19 For
example, multiple MALDI-IMS analyses were demonstrated for
single rat brain tissue sections by recoating the tissue after the
loss of matrix molecules. This allowed repeat lipid imaging at
>100 μm spatial resolution along with multiple MS/MS
experiments on a single tissue section.16 Furthermore,
successful application of dual polarity imaging of phospholipids
within a single mouse brain section was described with a spatial
resolution of 100 μm using a 50 μm offset in between the two
modalities.5
In the present study, we developed a three step, multimodal
MALDI-IMS paradigm (IMS3), for comprehensive imaging of
neuronal lipids and proteins at high spatial resolution (10 μm)
on the same mouse brain section. Here, we used a histology-
compatible MALDI-IMS approach20 based on sublimation of a
low-ionization energy matrix, 1,5-diaminonaphthalene (1,5-
DAN),5 facilitating subsequent, dual polarity lipid imaging in
positive- and negative-ion mode on the same pixel points. This
was followed by temperature-controlled spraying of 2,5-
dihydroxy-acetophenone (2,5-DHA) matrix for subsequent
protein imaging, which allowed acquisition and correlation of
lipid and protein/peptide imaging data within specific brain
regions on the same mouse brain tissue section. The optimized,
trimodal imaging MS workflow was then applied to probe
amyloid-β plaque-associated lipids and Aβ peptide isoforms in a
transgenic mouse model (tgArcSwe) of Alzheimer’s disease.
■ RESULTS AND DISCUSSION
High-Resolution (10 μm), Dual Polarity Lipid MALDI-
IMS on the Same Pixel Points. For sensitive and
reproducible MALDI-IMS analysis at high spatial resolution,
the choice of matrix compound and matrix application
technique are the key factors.5 Most wet matrix deposition
techniques can lead to lateral analyte diffusion, which impacts
spatial resolution.21 High laser fluence, as required for certain
MALDI matrices, can furthermore cause extensive matrix
cluster formation,13,20 in-source fragmentation,13 as well as
impact the molecular tissue morphology, all resulting in analyte
delocalization and tissue distortion.20 Therefore, it is important
to choose a sensitive matrix compound for the respective target
analytes in conjunction with a compatible matrix application
Figure 1. Effect of number of laser shots (5, 10, 20, 30, 50, 100) on (a) total signal intensity of lipid peaks in negative ion mode (300−2000 Da,
excluding matrix peaks) and (b) total signal intensity of matrix-derived peaks (300−650 Da) acquired on cerebellar areas equivalent in size (80 pixel
points) and morphology. (c) The ratio of the total signal intensity of lipid peaks to total signal intensity of matrix derived peaks in negative ion mode
(red) (d−f). Positive ion signals (blue) following negative ion mode imaging experiments on the same pixel point. (d) Total signal intensity of lipid
peaks and (e) matrix-derived peaks in positive polarity along with the ratio of the total signal intensity lipid peaks to matrix-derived peaks (f)
obtained by subsequent imaging in positive ion mode on the same pixel points. Zero shots (positive polarity) data were obtained from an equivalent
nonirradiated area using a constant number of laser shots (50). Error bars: SD (n = 5).
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protocol to obtain spatially well-resolved, intense ion signals
while preserving the tissue morphology.20
Here, we investigated high-spatial resolution (10 μm) dual
polarity MALDI imaging mass spectrometry of lipids within the
mouse cerebellum using an approach based on sublimation of
1,5-DAN for matrix deposition.5 Despite the high abundance of
lipids and their efficient ionization behavior in MALDI, the
structural diversity of lipids and the complexity of the laser
desorption/ionization process limit comprehensive lipid
profiling within a single IMS analysis. For example,
sphingomyelins (SM), phosphatidylcholines (PC), and neutral
lipids such as triacylglycerols (TG) and cerebrosides (Crb) are
usually observed in positive ion mode, whereas other
phospholipids, including phosphatidylinositols (PI), phospha-
tidylserines (PS), phosphatidylethanolamines (PE), and
phosphatidylglycerols (PG) along with several other glyco-
sphingolipids and cardiolipins (CL) are observed in negative
ion mode.22 Dual polarity lipid analysis of the same tissue
section could help to resolve this issue.19 For this purpose,
matrix compounds that provide efficient ionization in both
polarities, such as 1,5-DAN,18 DHB,21 and DHAP23 are
required. The particular advantage of 1,5-DAN as a matrix is
its low ionization energy18 and sensitivity for lipid molecules,
which provides high spectral quality at low laser fluence20 and
in turn results in minimized laser ablation-induced tissue
distortions as visualized by subsequent immunofluorescence
staining.20 This “gentle” desorption/ionization process, partic-
ularly in negative mode, allows for preservation of tissue
morphology and shows minimal mechanical tissue distortion,
respectively, along with limited consumption of lipids. This
facilitates efficient subsequent lipid analysis in positive ion
mode on the very same raster spot.
In order to investigate the performance of subsequent,
multimodal lipid MALDI imaging mass spectrometry on the
same imaging pixel array, cerebellar regions in sagittal mouse
brain tissue were analyzed (Figure 1, Supporting Information
Figure S-1). Here, the impact of laser fluence was studied using
different numbers of laser shots (5, 10, 20, 30, 50, 100) in
negative ion mode, followed by IMS in positive polarity on the
same pixel points using a constant number of laser shots (n =
50). The number of laser shots in positive ion mode was
optimized before on a nonpre-analyzed, cerebellar area,
equivalent in size and morphology (Supporting Information
Figure S-1d−f).20
When applying this approach for negative ion mode analysis,
the total signal intensity of lipids over a mass range of 300−
2000 Da, while excluding all matrix peaks, displayed a
significant decrease as soon as the number of laser shots was
increased beyond 10 (Figure 1a). This was accompanied by a
significant increase in total ion intensity of matrix-derived
signals, most prominent between 300 and 650 Da. (Figure 1b,
Supporting Information Figure S-1a−c), indicating a reduced
lipid ionization efficiency (Figure 1a,b). This is further
illustrated when considering the ratio of total negative ion
lipid intensity (300−2000 Da, excluding matrix peaks) and total
matrix peak intensity (300−650 Da), where the steepest slope
is observed between a stepwise increase from 10 to 20 laser
shots (Figure 1c).
The low-ionization energy of 1,5-DAN18 allows enhanced
ionization of lipid species at small laser focus parameters
without the need of high laser pulse energies and number of
laser shots (Supporting Information Figure S-1).20 On the
other hand, for analysis in both polarities, an increasing number
of laser shots results in lipid ion suppression due to formation
of excessive amounts of matrix- ions and -clusters in the
ablation plume (Supporting Information Figure S-1a−f). This is
explained by the fact that sublimation results in smaller crystals
that in turn result in higher temperatures during the
nanosecond laser desorption/ionization process as the smaller
crystal lattices do not allow for heat dissipation.24 This effect
results in both enhanced analyte- and matrix ionization. 1,5
DAN forms radicals upon laser irradiation that in turn result in
matrix cluster formation. Therefore, when higher laser fluences
are applied and thereby higher temperatures are generated in
the ablation plume, extensive cluster formation is observed,
which in turn results in analyte suppression.24
It is therefore crucial to optimize the laser fluence, to
minimize matrix suppression effects in order to facilitate
efficient lipid ionization. Moreover, minimizing cluster
formation provides improved spectral coverage (<m/z 650)
and detection of physiologically relevant lipid signals, including,
e.g., ceramides (Cer), due to less convolution by matrix cluster
ion peaks in the corresponding mass region (Supporting
Information Figure S-1g−j).20
In addition to these effects, increased laser power can result
in spatial overlapping effects that compromise sensitivity and
spatial resolution.
In general, when using 1,5-DAN, spectral data were found to
be more complex and intense in negative ion mode as
compared to positive ion mode data, including more prominent
matrix clusters signals (Supporting Information Figure S-1a−
f).5,20 This can be attributed to distinct reductive properties and
radical ion transfer abilities of 1,5-DAN18 as compared to
several other matrixes.5,20 Indeed, 1,5-DAN as a basic matrix
compound can act as a “proton sponge” in the gas phase which
can partially suppress protonation of lipids. In addition, as only
a few number of low-energy laser shots are required for
desorption and ionization in negative ion mode, plasma
shielding effects are minimized.25−27 These plasma shielding
effects occur, when a high numbers of laser shots are used at
high repetition rates and lead to absorption, scattering, and
diffuse reflection of incident laser light by the ablation plume,
which in turn can result in reduced ablation efficiency and lipid
ionization sensitivity.
Using low number of shots in negative ion mode, as
facilitated by the superior ionization sensitivity of 1,5-DAN,
results further in minimized-mechanical distortion and
consumption of lipids on a given coordinate of matrix-coated
tissue.20 Beyond the reduced spectral convolution, allowing
detection of physiologically relevant lipids below 650 Da, the
use of low numbers of laser shots also allows for sensitive,
subsequent analysis in positive ion mode on the same imaging
region and even on the same pixel points.
Indeed, the total ion intensity of positive lipid signals (300−
2000 Da, excluding matrix signals) acquired from the exact
same imaging MS pixel array showed maintained high intensity
after 5−10 laser shots in the preceding negative ion mode
analysis, as compared to a nonpre- irradiated tissue area (Figure
1d). In contrast, a characteristic decrease of total positive lipid
intensity, as well as matrix signal, was observed after the
acquisition of 10 laser shots in preceding negative ion mode
analysis (Figure 1d,f), indicating overall decreased spectral
quality. This can be explained by the increased mechanical
ablation and consumption of lipid and matrix molecules along
with the distortion of matrix-coating, which could impair laser
desorption/ionization geometry for subsequent laser shots on
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the given coordinates and result in generally decreased spectral
quality.
Finally, considering the structured beam profile of the smart
beam laser28 used in these experiments, an increasing number
of laser pulses can also result in inhomogeneous ablation
profiles on the matrix-coated brain tissue. The following laser
desorption on the same pixel points can result in an
inhomogeneity of the subsequent laser-desorption plumes,
which is reflected in an increased standard deviation of the total
signal intensities of lipids and matrix in positive ion mode on
the same raster spots as observed in the present study (Figure
1a,d and b,e).
Taken together, the optimization steps of dual polarity lipid
imaging MS revealed that a number of 10 laser shots in the first
IMS stage perfomed in negative mode provides high spectral
quality in both subsequent IMS stages, while higher laser
Figure 2. High-resolution, dual polarity MALDI-IMS of lipids on the same pixel points in the cerebellum in sagittal mouse brain sections. IMS data
were collected both in (a) negative and (b) positive ion mode with a lateral resolution of 10 μm at the same pixel points. (a) In negative ion mode,
ceramide 1-phosphates (CerP 18:0), phosphatidylglycerols (PG 34:1), phosphatidylethanolamines (PE 38:4, PE 38:6), phosphatidylserines (PS),
and phosphatidylinositols (PI) were found to localize to the molecular layer (ML) and granular layer, while sulfatides (ST 22:0 (OH), ST 24:0)
localized to white matter (WM). (b) In positive ion mode, lysophospatidylcholines (LPC 16:0) and phosphatidylcholines (PC 32:0, PC 33:1, PC
34:1, PC 35:3, PC 36:4, PC 38:6) were detected in both GL and ML or selectively in the ML (as for PC 40.6, PC 40:7). In contrast, sphingomyelin
(SM 36:1) was selectively observed in WM. Scale bar: 200 μm.
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fluences lead to decreased lipid signals and higher matrix
intensity for the negative ion mode analysis. Moreover, the
matrix preparation is affected for subsequent positive ion mode
IMS, resulting in generally decreased spectral quality. Similarly,
higher numbers of laser shots (>50) in the second stage,
positive ion mode IMS, result in decreased lipid signal and
increased matrix cluster formation (Supporting Figure S-1e,f).
Following the optimization experiments, we performed high-
resolution (10 μm) dual polarity lipid imaging of cerebellar
regions on sagittal mouse brain sections (Figure 2). Here, lipid
ion images in both negative and positive polarities could be
simultaneously visualized for the specific cerebellar regions,
including cerebellar -white matter, granular- and molecular-
layers (Figure 2a,b).
For example, inspection of lipid ion imaging data acquired in
negative mode at 10 μm resolution showed that ceramide 1-
phosphates (CerP 18:0) localized densely to the cerebellar
molecular layer, whereas phosphatidylinositols (PI 38:4 and PI
36:4), as well as phosphatidylethanolamines (PE 38:4), were
detected in both the granular and molecular layers where PI
38:4 was particularly elevated in the Purkinje cell layer. In
contrast, sulfatides (ST 22:0(OH), ST 24:0) localized to the
Figure 3. High-resolution (10 μm), trimodal MALDI imaging MS data acquired on the same IMS region in mouse cerebellum. (a,b) Dual polarity
MALDI-IMS of lipids in negative ion mode a) and b) positive ion mode was followed by high-resolution (10 μm) protein imaging on the same IMS
region (c). Protein signals were attributed based on accurate mass and literature values,31 including: m/z 5483 cytochrome c oxidase 7c (Cox7c); m/
z 6907 histone H2B [M+2H]2+; m/z 7062 myelin basic protein (MBP) 14 kDa [M+2H]2+; m/z 7690 histone H3 [M+2H]2+; m/z 9218 MBP 18
kDa [M+2H]2+; m/z 14 126 MBP 14 kDa; m/z 15 386 histone H3. m/z 8406 could not be attributed; WM, ML, and GL represent white matter and
molecular and granular layers, respectively (a). Scale bar: 200 μm.
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white cerebellar matter region. (Figure 2a) Lipids acquired in
positive ion polarity, such as lysophosphatidylcholines (LPC
16:0) and phosphatidylcholines (PC 32:0, PC 33:1, PC 34:1,
PC 35:3, PC 36:4, PC 38:6) were detected in both granular and
molecular layers, whereas SM 36:1 was selectively observed in
the white matter (Figure 2b). Moreover, PC 40:7 and PC 40:6
species were lower in the granular layer but characteristically
abundant in the Purkinje cell layer, while PC 32:0 and PC 34:1
were selectively depleted in that region (Figure 2b).
Dual Polarity Lipid MALDI-IMS Followed by Protein
MALDI-IMS on the Same Imaging Region at 10 μm
Spatial Resolution. The diversity of molecular target species
and the mass range of different MALDI IMS analyses modes
are directly related to the choice of matrix compounds and their
compatibility with matrix application strategies. Therefore,
subsequent multimodal MALDI IMS analysis of lipids and
proteins typically requires the use of multiple matrix
compounds and corresponding tissue washing and matrix
deposition procedures.
We here investigated the potential of a trimodal, repeat
MALDI IMS approach at 10 μm spatial resolution to probe the
distribution of lipids and proteins on the same imaging area
within the same tissue section. For that, we used the previously
described histology-compatible MALDI-IMS20 approach based
on 1,5-DAN matrix sublimation5 for dual polarity MALDI-IMS
of lipids (Figure 2). This was followed by MALDI IMS of
proteins on the same region within the mouse cerebellum
previously analyzed for lipids (Figure 3). MALDI imaging of
proteins was based on 2,5-dihydroxyacetophenone (2,5-DHA),
which was previously demonstrated to be a highly sensitive and
adequately vacuum stable matrix compound for MALDI IMS of
proteins.29,30 This workflow, however, results in tissue surface
distortion, due to higher laser fluence needed for protein
ionization and consequently laser-induced, mechanical stress as
revealed by subsequent H&E staining, which does not allow for
subsequent histological immunostaining experiments. (Sup-
porting Information Figure S-2). Despite this limitation, the
here demonstrated trimodal imaging paradigm allows identi-
fication of colocalizing lipid (Figure 3a,b) and protein signals
(Figure 3c), acquired from the same imaging region.
As illustrated by an overlay of individual ion intensity
patterns from the trimodal imaging data, this method allowed
to elucidate corresponding and complementary chemical
distribution patterns with respect to anatomical regions of
interest, including the cerebellar white matter, granular layer
and molecular layer (Figure 4a−h).
For example, sphingomyelins (SM 36:1, m/z 731.7) detected
in positive ion mode and expressed in the white matter could
be overlaid with phosphatidylglycerols (PG 34:1, m/z 747.5)
detected in negative ion mode and expressed in granular and
molecular layers, demonstrating the complementary distribu-
tion of multimodal imaging data (Figure 4b). Protein signals
for, e.g., cytochrome c oxidase 7c (Cox7c, m/z 5483, Figures 3c
and 4c), and myelin-basic protein (MBP, m/z 9218, [M+2H]2+,
Figures 3c and 4d) that localized to the molecular layer and
white matter, respectively, were overlaid with lipids, including
sulfatides (ST 24:0, m/z 890.6, white matter, Figure 4c)
acquired in negative ion mode and phosphatidylcholines (PC
33:1, m/z 746.6, molecular layer, Figure 4d) acquired in
positive ion mode that displayed similar or complementary
localization pattern. Similarly, MBP 14 kDa and PE 34:1
localized complementarily to white matter and molecular layer,
respectively (Figure 4e).
An overlay of SM 36:1 (m/z 731.7) and histone H3 (m/z
7690, [M+2H]2+) highlights the distinct localization of histone
H3 to the granular layer (Figure 4f). This can be attributed to
the cell nuclei in the cell body rich granular layer as these
contain larger amounts of histones that stabilize chromatin in
the cell nuclei. Triple overlay data further demonstrate how
ceramides (CerP 18:0, m/z 644.6) and sphingomyelins (SM
Figure 4. Overlaid multimodal ion images for lipids acquired in negative (green) and positive (red) ion mode together with proteins signals (blue)
obtained on the same region in the cerebellum. The data display the same cerebellar area of a sagittal mouse brain section as illustrated in Figure 3.
(a) Bright field image, outlining the major cerebellar areas including the white matter (WM), granular (GL) and molecular layer (ML). (b) Overlay
images of dual polarity lipid signals for SM 36:1 (red, m/z 731.7) and PG 34:1 (green, m/z 747.5). (c−h) Overlay images for multimodal imaging
data including lipid- and protein-signals: (c) ST 24:0 (green, m/z 890.6) and Cox7c (blue, m/z 5483); (d) PC 34:1 (red, m/z 760.6) and MBP
(blue, m/z 9218, [M+2H]2+); (e) PE 38:4 (green, m/z 766.6) and MBP (blue, m/z 14126); (f) SM 36:1 (red, m/z 731.7) and histone H3 (blue, m/
z 7690 [M+2H]2+); (g) CerP 18:0 (green m/z 644.6), SM 36:1 (red, m/z 731.7), and histone H3 (blue, m/z 15386; (h) MBP (blue, m/z 14126),
PS 40:6 (green, m/z 834.6), and PC 40:6 (red, m/z 834.7). Scale bar: 200 μm.
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36:1, m/z 731.7) are expressed in the molecular layer and white
matter, respectively, while histone H3 (m/z 15386, [M+H]+)
localizes characteristically to the granular layer (Figure 4g).
Similarly, an overlay of MBP, PS 40:6 and PC 40:6 highlights a
complementary localization to the white matter (MBP),
molecular layer (PS) and the Purkinje cell layer (PC) (Figure
4h). Here, the high spatial resolution of this methodology
allows visualizing individual neuronal cell bodies in the Purkinje
cell layer as outlined by localization of PI 36:4 (Figure 3a) and
PC 40:6 and 40:7 (Figures 3b and 4h). These results highlight
the potential of trimodal MALDI imaging to probe biochemical
correlates of pathohistological features at cellular scales.
Consequently, this method provides a powerful approach to
correlate lipid and protein localizations to histopathological
features including abnormal protein aggregation characteristic
for neurodegenerative diseases like, e.g., Alzheimer’s (AD),
Parkinson’s (PD), or prion diseases in order to probe the
complex chemical interactions underlying proteopathy in these
diseases.32
High-Resolution (10 μm) Multimodal MALDI-IMS
Reveals Amyloid Plaque-Associated Lipids and Aβ
Isoforms in Transgenic Alzheimer’s Disease Mice
(tgArcSwe). The neuropathology of AD is characterized by
loss of memory and cognition as a consequence of progressive
neuronal degeneration. This has been suggested to be due to
impairment of hippocampal synaptic efficacy caused in part by
diffusible extracellular amyloid-β (Aβ) aggregates.33,34 Aβ
accumulation has been suggested to trigger AD pathogenesis,34
where Aβ peptides rapidly aggregate to form oligomers,
protofibrils, and fibrils, eventually leading to the formation of
extracellular plaques.35 However, the molecular mechanisms of
this process are not fully understood. A number of studies
suggest that, along with Aβ peptide-related mechanisms, several
lipid species including cholesterol,36,37 sphingolipids,20,38−40
and phospholipids40−42 can have prominent roles in Aβ plaque
pathology in AD.39,43 Therefore, high-resolution multimodal,
chemical imaging methods can be a powerful strategy to
disentangle the multiple aspects of molecular amyloid
pathology in situ.
Our group has previously studied the expression pattern of
amyloid plaque-associated Aβ peptides44 and sphingolipids20,38
in transgenic AD mice (tgArcSwe and tgSwe) using multimodal
chemical imaging strategies. Therefore, we employed the here
described comprehensive multimodal MALDI-IMS approach to
delineate the distribution patterns of positively and negatively
charged lipid species along with the Aβ peptide isoforms
associated with amyloid plaque pathology in transgenic AD
mice (tgArcSwe) (Figure 5). This mouse model carries both
the Arctic (E693G) and the Swedish (K670M/N671L)
mutation and displays extensive Aβ deposition with an early
onset age of 5−6 months. It is, therefore, a well-suited model
system to study Aβ pathology.45 We performed trimodal
MALDI-IMS on 18-month-old tgArcSwe mice brain tissue
sections for comprehensive lipid and peptide imaging to
elucidate Aβ plaque associated localizations/alterations of lipid
species potentially implicated in AD pathology. Indeed, the
results reveal a prominent colocalization for various lipid
Figure 5. Hippocampal amyloid plaque-associated lipids in dual polarity and peptides (a) on a coronal mouse brain tissue section of transgenic AD
mice (tgArcSwe) were revealed by multimodal MALDI-IMS. (b) Hippocampal region analyzed with 10 μm spatial resolution. (c) Ion images of
lipids: ceramides (Cer d18:1/18:0, m/z 564.6), phosphatidylinositols (PI 38:4, m/z 885.6), sulfatides (ST 24:0, m/z 890.6) acquired in negative
(green) and lysophosphatidylcholines (LPC 16:0, m/z 496.3, LPC 18:0, m/z 524.3) and posphatidylcholines (PC 32:0, m/z 734.6) acquired in
positive (red) ion mode with subsequently acquired amyloid-β (Aβ 1−37, m/z 4002.7, Aβ 1−38, m/z 4060.3, Aβ 1−40, m/z 4257.6) peptide (blue)
ion images within the same imaging region.
ACS Chemical Neuroscience Research Article
DOI: 10.1021/acschemneuro.7b00314
ACS Chem. Neurosci. 2017, 8, 2778−2790
2784
species analyzed in dual polarity and several amyloid-β peptides
(Figure 5).
Inspection of the ion images revealed that lipids obtained in
negative polarity (green), including ceramides (Cer d18:1/18:0,
m/z 564.6), phosphatidylinositols (PI 38:4, m/z 885.6) and
sulfatides (ST 24:0, m/z 890.6), display strong colocalization
with ion images of lipids obtained in positive polarity (red),
including lysophosphatidylcholines (LPC 16:0, m/z 496.3, LPC
18:0, m/z 524.3) and posphatidylcholines (PC 32:0, m/z
734.6) (Figure 5c). Moreover, a strong colocalization of the
lipid accumulations was observed with intensity distributions of
various amyloid β peptides (blue) (Aβ 1−37, m/z 4002.7, Aβ
1−38, m/z 4060.3, Aβ 1−40, m/z 4257.6) (Figure 5c).
An overlay of the trimodal IMS data revealed that plaque
feature-like localization patterns observed for various lipid
species were shown to be attributed to the Aβ plaques as
verified by the peptide imaging data (Figure 6). Furthermore,
immunohistochemistry (IHC) staining was performed using a
monoclonal Aβ antibody (Aβ1−16, 6E10) following MALDI-
IMS analysis of lipids in negative ion mode, which further
verified the amyloid identity of the aggregates (Supporting
Information Figure S-3). As a further control, MALDI-IMS data
for negative ion mode lipids were collected in the hippocampal
region of 18-month-old control, wild-type mice to verify that
the lipid accumulations observed are related to amyloid plaque
pathology. Here, no plaque-like accumulation patterns or
general elevations were observed for the lipid species that show
plaque localization in transgenic mice (Supporting Information
S-4). This further verifies the relevance of the here observed
lipid distribution in Aβ pathology.
Aβ plaque-associated ceramide elevation and sulfatide
deficiency, as observed here, was previously described for the
same transgenic mouse model (tgArcSwe) using MALDI-
IMS.38 Here, the same phenomenon was observed explicitly at
high-spatial resolutions. (Figure 6b) Moreover, shotgun
lipidomics studies of transgenic AD mice and human AD
brain homogenates consistently indicated the same results.46
Sulfatides are highly enriched in myelin sheaths and mainly
synthesized by oligodendrocytes playing key roles in the
regulation of oligodendrocyte maturation and myelin for-
mation.47 Indeed, it has been hypothesized that alterations of
apolipoprotein E (APOE) ε4 allele-mediated sphingolipid
homeostasis through lipoprotein metabolism pathways can
lead to depletion of sulfatides in AD pathogenesis.48 Moreover,
the substantial increase in ceramide content are suggested to be
a potential result of sulfatide degradation, but other
explanations include membrane-associated oxidative stress37
or accelerated hydrolysis of sphingomyelin.46,49 Indeed,
oligondendrocytes are highly susceptible to oxidative stress
possibly due to the demanding energy for the production of
lipid-rich and protein-dense myelin sheaths.50,51 Therefore,
amyloid plaque-associated perturbation of sulfatide homeostasis
can be associated with the regression of myelination, which is
another pathological hallmark of Alzheimer’s disease.52
The increase in lysophosphatidylcholines (LPC) and
decrease in phosphatidylcholines (PC) have been previously
reported in hippocampus, cortex and subiculum of another
transgenic AD mice (5XFAD) using MALDI-IMS.41 Further,
immunostaining of PLA2 showed partial PLA2 localization
around amyloid plaques.41 This suggests an amyloid-plaque
associated hyperactivity of PLA2, which causes amyloid-
associated alterations of LPCs and PCs. Indeed, Aβ exerts its
cytotoxic effects mainly perturbing cellular membranes, partially
through the modulation of the activity of phospholipases, such
as PLA2
53 and PLC.54 Moreover, increased neuronal activity of
PLA2 converts PC to LPC, which stimulates glial cells and
subsequently induces neuroinflammation.55 Our high-spatial-
resolution, trimodal MALDI-IMS approach reveals amyloid
plaque-associated elevations of LPCs which is directly
correlated with sphingolipids on the same plaques (Figure
6a,d). On the other hand, the plaque specific elevation of
lysophosphatidycholines can be attributed to their roles in Aβ
oligomerization and fibril formation.42,56 Finally, it is also well-
known that LPC induces demyelination via glial LPA
signaling.57 This further links LPC localization to plaque-
associated demyelination as observed in AD,52 which is in line
with the plaque-associated sulfatide dyshomeostasis.38
We further observed a significant elevation of phosphatidy-
linositols (PI 38:4, m/z 885.6) on amyloid plaques (Figure
6c,f). Interestingly, while previous reports described a general
reduction of these species in hippocampus and cortex tissue of
human AD brains,58,59 we observed a plaque specific increase.
Figure 6. Overlaid images of hippocampal amyloid plaque-associated lipids and amyloid peptides in Figure 5. (a) LPC (18:0) and Cer (18:0), (b)
Cer (18:0) and ST (24:0), (c) PI (38:4) and ST (24:0), (d) LPC (16:0) and ST (24:0), (e) ST (24:0) and Aβ 1−40, and (f) PI (38:4), ST (24:0)
and Aβ 1−40. Scale bar: 250 μm.
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While this can be due to possible differences in amyloid
pathogenesis of human AD and transgenic AD mice
(tgArcSwe), our approach reports spatially resolved local-
izations of these species to Aβ plaques at 10 μm spatial
resolution (Figure 6c,f). Previous findings are based on brain
extracts and therefore lack the spatial aspect of analysis, making
pathology specific correlation analysis impossible. Indeed, PI
lipids were previously identified to play a role in amyloid fibril
growth.60 Moreover, an AD-associated reduced phosphatidyli-
nositol kinase activity61 along with the dysregulated phospha-
tidylinositol-4,5-bisphosphate metabolism by oligomeric amy-
loid-β peptide54 were previously reported, which could be
possible pathways for plaque-associated PI elevation. This
highlights the potential of the here employed high-resolution,
multimodal MALDI-IMS approach that allows for simultaneous
analysis of lipids and peptides in a single microscale Aβ plaque
region within a specific brain area (Figures 5 and 6).
On the other hand, this approach suggests an improved
strategy for validation of the amyloid identity of Aβ aggregates,
as compared to immunohistochemical assessment. This is due
to the limitations of antibody-based approaches with respect to
specificity and comprehensiveness, as IHC only allows for
simultaneous detection of one or two relevant Aβ isoforms at
sometimes questionable specificity.38,44 In contrast, the here
presented approach offers a possibility to correlate multiple
isoforms at once with high chemical specificity. This is further
inferred, with the possibility for in situ validation through MS/
MS experiments.
In Situ MS/MS Based Identification of Aβ Plaque-
Associated Lipids and Peptides. In MALDI, fragmentation
strategies such as collision induced dissociation (CID),62 post
source decay (PSD),63 and in-source decay (ISD)64 have been
used for in situ identification of analytes directly on the tissue
section. However, in situ MALDI MS/MS using PSD, as
enabled on a TOF/TOF instrument, is challenging due to
suppression effects and the lower fragmentation efficiency of
PSD. This approach is therefore, time-consuming and requires
a lot of laser shots for spectra acquisition, resulting in increased
consumption of analyte and matrix, which in turn facilitates
only a few MS/MS experiments. However, histopathological
accumulations of certain lipid- and amyloid peptide species on
plaques or other histological features provide a natural
preconcentration, enabling efficient MS/MS analysis on plaque
aggregates in situ. The potential of this approach for in situ
identification of neuronal lipid species was previously
demonstrated by our group.20,38 Therefore, we applied
MALDI MS/MS analysis in LIFT-TOF/TOF mode for lipids
and peptide fragmentation following MALDI-IMS analysis of
the corresponding modality (Figure 7).
The results demonstrate the potential of this approach for in
situ identification of lipids and peptide including Cer (d18:1/
18:0) and Aβ 1−40, directly on plaque aggregates. Here,
diagnostic fragment ions for Cer (d18:1/18:0) (Figure 7a) and
other plaque-associated neuronal lipids (Supporting Informa-
tion Figure S-5) allowed identification of the corresponding
lipid species. Moreover, for MS/MS analysis of Aβ 1−40 a
multitude of sequence specific b- and y-fragment ions were
detected (Figure 7b), yielding a high-degree of confidence in
the sequence identity (Supporting Information Figure S-6).
The here presented multimodal MS/MS data further highlight
the potential of the approach for comprehensive, molecular
analysis of complex biological tissues with high chemical
specificity.
■ CONCLUSIONS
We here present a trimodal MALDI-IMS paradigm that allowed
for subsequent acquisition of lipid data in positive and negative
polarity from the same pixel point followed by protein imaging
all at 10 μm spatial resolution. This enabled identification of
colocalizing lipids and protein species within the same tissue
section. The results demonstrate the potential of this approach
for comprehensive molecular imaging of cerebellar lipid and
protein species, delineating histological features and anatomical
regions of interest. Moreover, an application to a transgenic
mouse model of AD (tgArcSwe) revealed amyloid plaque-
associated lipid species that were colocalized with distinct Aβ
peptide isoforms. Therefore, this approach can substantially
increase the potential for multimodal MALDI imaging MS to
comprehensively probe neurodegenerative disease pathologies
in situ.
■ METHODS
Chemicals and Reagents. All chemicals for matrix and solvent
preparation were pro-analysis grade and obtained from Sigma-Aldrich
(St. Louis, MO), unless otherwise specified. TissueTek optimal cutting
temperature (OCT) compound was purchased from Sakura Finetek
(AJ Alphen aan den Rijn, The Netherlands). The ddH2O was
obtained from a Milli-Q purification system (Merck Millipore,
Darmstadt, Germany).
Animals. C57BL/6 female mice from Charles Rivers Laboratories
were used for method development (Sulzfeld, Germany). The animals
were housed at the animal facility in Gothenburg (Laboratory of
Experimental Biomedicine, EBM), kept under standard conditions of
daylight (12 h light cycle), and provided with food and water ad
Figure 7. Multimodal tandem mass spectrometry of lipid and peptide
species in situ. MS/MS acquisition on plaque features as exemplified
for (a) Cer (d18:1/18:0, m/z 564.6) and (b) Aβ (1−40, m/z 4257.6).
Diagnostic fragment ions are annotated for Cer (d18:1/18:0) (a) as
well as sequence specific N-terminal (b) and C-terminal (y) fragment
ions for Aβ 1−40, allowing unambiguous identification of lipids and
peptides in situ.
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libitum. Animals were delivered with their respective dams that were
further separated at postnatal day (PND) 21 of the pups. Transgenic
mice, 18 months of age, with the Arctic (E693G) and Swedish
(K670N, M671L) mutations (tgArcSwe) of human APP were reared
ad libitum at the animal facility at Uppsala University under a 12 h/12
h light cycle. All animal procedures were approved by an ethical
committee and performed in compliance with national and local
animal care and use guidelines (DNr #C17/14 at Uppsala University).
Tissue Collection and Sectioning. The animals were anes-
thetized with isoflurane and sacrificed by decapitation. The brains were
dissected quickly with 3 min postmortem delay and frozen on dry ice.
Frozen tissue sections (12 μm thick) were cut in a cryostat microtome
(Leica CM 1520, Leica Biosystems, Nussloch, Germany) at −18 °C,
and collected on indium tin-oxide (ITO) coated conductive glass
slides (Bruker Daltonics, Bremen, Germany) and stored at −80 °C.
MALDI IMS Sample Preparation and Matrix Application.
Prior to matrix application, tissue sections were thawed in a desiccator
for ∼30 min under reduced pressure (SpeedVac, Eppendorf,
Hamburg, Germany). The ITO glasses were marked with a glass
cutter (Starwalker, Montblanc, Germany) to give sharp-edged cross
features for the teaching of the navigation points in the MALDI
imaging acquisition software (Flex Imaging, v3.0, Bruker Daltonics).
The mounted tissue sections were scanned in a histology slide scanner
(PathScan Enabler IV, Electron Microscopy Sciences, Hatfield, PA).
Matrix deposition for lipid analysis was carried out by sublimation of
1,5-diaminonaphthalene (1,5-DAN) using a vacuum sublimation
apparatus (Sigma-Aldrich). The sublimation chamber was connected
to a membrane vacuum pump (Jula, Skara, Sweden) attached to a
digital vacuum gauge controller and placed in a heated sand bath
(SiO2, 50−70 mesh particle size, Sigma-Aldrich) on a hot plate (C-
MAG HP 4, IKA Werke GmbH & Co. KG, Staufen, Germany) and
connected to an electronic contact thermometer (ETS-D5, IKA Werke
GmbH & Co. KG, Staufen, Germany). Sublimation was performed by
the following steps. First, thawed and vacuum-dried (∼20 min) ITO-
glass slides with the thaw-mounted mouse brain tissues were attached
to the flat top of the chamber using double-sided heat conductive
copper tape. Then, ∼300 mg of 1,5 DAN matrix powder was placed
evenly on the outer bottom of the sublimation chamber, which was
then attached to the top using the O-ring seal. A reduced pressure of
0.8 mbar was applied and the system was allowed to equilibrate under
vacuum for a period of ∼20 min. The sand bath temperature was set to
130 °C. The cooler was filled with ice slush (≥0 °C) for condensation
of the matrix on the sample slides. The sublimation time was 20 min.
The process was halted by removing the sublimation apparatus from
the sand bath and closing the vacuum valve. The sublimation
apparatus was allowed to slowly re-equilibrate to atmospheric pressure
before removal of the sample plate. The amount of deposited matrix
on ITO glass was determined using a high-precision scale (AX224,
Sartorius, Göttingen, Germany) weighing the amount before and after
the sublimation experiments. The sublimation protocol was optimized
with respect to temperature, deposition time and the total amount of
deposited matrix to obtain the best detection efficiency for lipids on
mouse brain tissue. With this setup, the optimum matrix layer was
found to be 120 μg/cm2 to give the best lipid signals.20 Here, a too
thin matrix layer (50−70 μg/cm2) yielded very few lipid ions, while a
too thick matrix layer (200−300 μg/cm2) resulted in dominant matrix
ions (Supporting Information S-7).
Prior to protein imaging, tissue sections were washed 2× 100%
ethanol (EtOH) (30s) to remove the remaining 1,5-DAN matrix.
Lipids and salts were washed away in sequential washes of 70% EtOH
(30 s), 100% EtOH (30 s), Carnoy’s fluid (6:3:1 EtOH/chloroform:-
acetic acid) (2 min), 100% EtOH (30 s), H2O with 0.2% TFA (30 s),
and 100% EtOH (30 s).65
The teaching of the navigation points was performed using the same
sharped-edged cross points created with the glass cutter pen in the
preceding lipid analysis to minimize the repositioning error between
lipid and protein imaging mass spectrometry analysis. 2,5-Dihydrox-
yacetophenone (2,5-DHA) was used as matrix compound and applied
using a TM Sprayer (HTX Technologies, Carrboro, NC, USA)
combined with a HPLC pump (Dionex P-580, Sunnyvale, CA, USA).
Before every spraying experiment, the solvent pump valve was purged
first manually using a syringe followed by the implemented automatic
purging function for ∼10 min. The pump was then kept running at
isocratic flow with 100 μL/min using 70% ACN as pushing solvent for
3 h. A matrix solution of 15 mg/mL 2,5-DHA in 60% ACN/1%
CH3COOH/1%TFA was sprayed onto the tissue sections using the
following instrumental parameters: nitrogen flow (10 psi), spray
temperature (75 °C), nozzle height (40 mm), eight passes with offsets
and rotations, and spray velocity (1300 mm/min). Following the
matrix deposition, the preparations were recrystallized as described
previously.65 Here, the slides were mounted with copper tape on a top
of a Petri dish (100 mm diameter × 15 mm deep, VWR, Stockholm,
Sweden) with a filter paper pipetted with 5% methanol and placed on
the lower part of the dish. The glasses were closed and placed in an
oven at 85 °C for 3.5 min.
MALDI-IMS Analysis. Imaging MS was performed on a MALDI
TOF/TOF UltrafleXtreme mass spectrometer equipped with
SmartBeam II Nd:YAG/355 nm laser operating at 1 kHz providing
a laser spot diameter down to ∼10 μm for the “minimum” focus
setting (Bruker Daltonics). Measuring the absolute laser pulse energy
of a smartbeam II laser is challenging in UltrafleXtreme systems, as
such a measurement would require a reference measurement inside the
instrument, which would require modification of the instrument
hardware. Moreover, SmartBeam lasers do not have a flat-top shaped
beam energy profile, but a rather highly structured beam energy
profile, which makes it a hard task to measure the exact value of laser
fluence at a flat target surface.28 Therefore, rather than measuring the
laser pulse energy, we provide detailed information about the laser
pulse energy settings as previously indicated for lipid analysis in our
previous communication; global laser attenuator setting was kept
stable at 10% throughout all the experiments and the laser focus set to
minimum. Attenuator offset and attenuator range settings were 40%
and 10%, respectively, for the minimum laser focus.20 As SmartBeam II
lasers lose some energy output over the lifetime, it is necessary to
specify the laser shot count of the instrument unit used for this
experimentation, which was about 225696k (∼12 months age).
For dual polarity lipid analysis, profiling and imaging data
acquisitions were performed in reflective ion mode under optimized
delayed extraction conditions over a mass range of 300−2000 Da.
First, IMS data were acquired with five laser shots/per pixel point with
a source accelerating voltage of 20 kV in negative polarity (reflector
negative mode, RN). This was followed by 50 laser shots/pixel point
in positive polarity (reflector positive mode, RP) with a source
accelerating voltage of 25 kV. The detector gain value was kept stable
at 2626 V for both ionization modes.20 A mass resolution of M/ΔM
20 000 was achieved in the mass window of lipids (i.e., 650−1000 Da).
External calibration was carried out using peptide calibration standard
I (Bruker Daltonics). Image data were reconstructed and root-mean-
square (RMS) normalized to minimize pixel to pixel variations of
signal intensities (Supporting Information Figure S-8) and visualized
using Flex Imaging v3.0 (Bruker Daltonics). Lipid classifications on
control tissues were determined by comparing mass accuracy data with
the LIPID MAPS database (www.lipidmaps.org) and previous results
obtained on mouse brain tissue sections.5,20,38
For protein analysis on the same imaging region, the global laser
attenuator was increased to 35% while keeping attenuator offset and
range settings the same for minimum laser focus. Profiling and imaging
data acquisitions were performed in linear positive ion mode in a mass
range of 2000−20 000 Da. A number of 50 laser shots/raster spot were
acquired with 1 kHz repetition rate. Protein identifications were
determined by comparing the mass accuracy data with values reported
in the literature31
Further, identification of lipids and Aβ1−40 (m/z 4257.6) was
achieved by examining MS/MS spectra obtained in LIFT-TOF/TOF
mode. MALDI-LIFT (MS/MS) spectra were collected directly in situ
in LIFT mode with increased laser power (30%) until a satisfactory
intensity of fragment peaks were achieved. (Figure 7 and Supporting
Information Figure S-5 and S-6)
Data Analysis. Prior to data analysis, all spectra were calibrated
externally using the batch-processing function in Flex Analysis (v 3.0,
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Bruker Daltonics). Calibration spectra were obtained from calibrant
solution spots (Protein Calibration Mix 1, Bruker Daltonics) that were
placed adjacent to the tissue slides. For the evaluation of dual polarity
lipid analysis on the same pixel points, MALDI-IMS data from five
replicates of equal pixel-point (80) regions were acquired. Here,
cerebellar regions containing equally sized areas of anatomically
different cerebellar regions (molecular layer, granular layer, white
matter) were analyzed to account for their chemical diversity and
distinct stiffness.66 The laser power was kept constant and the number
of laser shots in negative ion mode has been changed to 5, 10, 20, 30,
50, 100 on different regions. Then, positive ion spectra have been
collected on the same pixel points along with an equivalent
nonirradiated area with a constant number of laser shots (50) as
previously optimized for best spectral quality at the laser pulse energy
described in MALDI-IMS analysis part.20 Determination of the
intensity of all discernible matrix derived peaks (300−650 Da) and
lipid peaks in both ion polarities (300−2000 Da, excluding all matrix
peaks) with S/N ≥ 3 were determined using Flex Analysis 3.0
software. The signal-to-noise calculation is using the intensity as the
“signal”. The noise calculation is a m/z dependent standard deviation
calculation that is done iteratively to remove the data points of peaks
which are considered as outliers on top of a background determining
the noise. The standard deviation was calculated using five replicates,
and the graphs were sketched with Igor Pro 6.3 (Wavemetrics, Lake
Oswego, OR).
Image Processing. Image registrations were performed in
MATLAB using three consecutive scripts developed in-house using
the implemented Image Processing Toolbox. Briefly, the scripts
contain cropping images exported from Flex Imaging 3.0, application
of transformations for image registration, and resizing/merging the
processed images. Brief explanations of the image processing toolbox
functions were provided above the scripts as comments. (Supporting
Information)
Post-MALDI-IMS H&E Staining. For H&E staining after trimodal
MALDI-IMS, the matrix was washed away using 2 × 1 min
submersions in 100% EtOH. The tissue was rehydrated in 70%
EtOH, 50% EtOH, and Milli-Q water for 2 min each. The slides were
placed in hematoxylin (HistoLab Products, Vas̈tra Frölunda, Sweden)
for 2 min and washed with Milli-Q water for 2 min. The slides were
then counterstained in 0.2% eosin (HistoLab Products) for 2 min and
washed in Milli-Q water for another 2 min. The section was finally
washed and dehydrated in 50% EtOH, 70% EtOH, and 100% EtOH
for 1 min each. The tissue sections were mounted with mounting
medium (Permount, eBioscience, Thermo Fisher Scientific) and
microscopic images were acquired using a wide-field microscope
(Zeiss Axio Observer Z1, Zeiss, Jena, Germany).
Immunohistochemistry. Following MALDI IMS analysis of
lipids in negative mode, the tissue sections were rinsed in absolute
EtOH for 120 s, fixed in 95% EtOH/5% AcOH at −20 °C for 8 min,
70% EtOH at −20 °C for 30 s, 70% EtOH at RT for 30 s, and then
stored in PBS prior to antibody staining. Here, a monoclonal antibody
specific for the Aβ1−16 epitope (6E10, 1 mg/mL, BioLegend, San
Diego, CA) was used as primary antibody, and goat anti-mouse IgG
conjugated to FITC 488 (Thermo Fisher Scientific) was used as
secondary antibody. The tissue was blocked for 1 h at room
temperature (RT) in PBS based blocking solution containing 5%
normal goat serum (NGS, Invitrogen, Thermo Fisher Scientific,
Carlsbad, CA), 2% bovine serum albumin (BSA, Sigma-Aldrich), and
0.3% Triton-X100 (TX100, Sigma-Aldrich). Incubation with primary
antibody (1:500) was performed overnight at 4 °C, and with
secondary antibody (1:1000) for 1 h at RT, both diluted in PBS
based diluent solution (0.05% NGS, 0.02% BSA, 0.3% TX100).
Unspecific binding of the secondary antibody was assessed by
incubation of in diluent solution without the primary antibody. Each
incubation step was followed by 3 × 5 min rinse in PBS. Prior to
imaging tissue was mounted with Prolong Gold antifade reagent
(Thermo Fisher Scientific) and dried for 2 h at RT. Imaging was
performed using a wide field microscope (Axio Observer Z1, Zeiss,
Jena, Germany).
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